Details der Publikation - Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up

Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up

Purpose The onset of the coronavirus disease 19 (COVID-19) pandemic in Italy induced a dramatic increase in the need for intensive care unit (ICU) beds for a large proportion of patients affected by COVID-19-related acute respiratory distress syndrome (ARDS). The aim of the present study was to describe the health-related quality of life (HRQoL) at 90 days after ICU discharge in a cohort of COVID-19 patients undergoing invasive mechanical ventilation and to compare it with an age and sex-matched sample from the general Italian and Finnish populations. Moreover, the possible associations between clinical, demographic, social factors, and HRQoL were investigated. Methods COVID-19 ARDS survivors from 16 participating ICUs were followed up until 90 days after ICU discharge and the HRQoL was evaluated with the 15D instrument. A parallel cohort of age and sex-matched Italian population from the same geographic areas was interviewed and a third group of matched Finnish population was extracted from the Finnish 2011 National Health survey. A linear regression analysis was performed to evaluate potential associations between the evaluated factors and HRQoL. Results 205 patients answered to the questionnaire. HRQoL of the COVID-19 ARDS patients was significantly lower than the matched populations in both physical and mental dimensions. Age, sex, number of comorbidities, ARDS class, duration of invasive mechanical ventilation, and occupational status were found to be significant determinants of the 90 days HRQoL. Clinical severity at ICU admission was poorly correlated to HRQoL. Conclusion COVID-19-related ARDS survivors at 90 days after ICU discharge present a significant reduction both on physical and psychological dimensions of HRQoL measured with the 15D instrument. Trial Registration: NCT04411459..

Medienart:	E-Artikel

Erscheinungsjahr:	2021
Erschienen:	2021

Enthalten in:	Zur Gesamtaufnahme - volume:30
Enthalten in:	Quality of life research - 30(2021), 10 vom: 12. Mai, Seite 2805-2817

Sprache:	Englisch

Beteiligte Personen:	Gamberini, Lorenzo [VerfasserIn] Mazzoli, Carlo Alberto [VerfasserIn] Sintonen, Harri [VerfasserIn] Colombo, Davide [VerfasserIn] Scaramuzzo, Gaetano [VerfasserIn] Allegri, Davide [VerfasserIn] Tonetti, Tommaso [VerfasserIn] Zani, Gianluca [VerfasserIn] Capozzi, Chiara [VerfasserIn] Giampalma, Emanuela [VerfasserIn] Agnoletti, Vanni [VerfasserIn] Becherucci, Filippo [VerfasserIn] Bertellini, Elisabetta [VerfasserIn] Castelli, Andrea [VerfasserIn] Cappellini, Iacopo [VerfasserIn] Cavalli, Irene [VerfasserIn] Crimaldi, Federico [VerfasserIn] Damiani, Federica [VerfasserIn] Fusari, Maurizio [VerfasserIn] Gordini, Giovanni [VerfasserIn] Laici, Cristiana [VerfasserIn] Lanza, Maria Concetta [VerfasserIn] Leo, Mirco [VerfasserIn] Marudi, Andrea [VerfasserIn] Nardi, Giuseppe [VerfasserIn] Ottaviani, Irene [VerfasserIn] Papa, Raffaella [VerfasserIn] Potalivo, Antonella [VerfasserIn] Ranieri, Vito Marco [VerfasserIn] Russo, Emanuele [VerfasserIn] Taddei, Stefania [VerfasserIn] Volta, Carlo Alberto [VerfasserIn] Spadaro, Savino [VerfasserIn]

Links:	Volltext [lizenzpflichtig]

BKL:	44.52$jTherapie$XMedizin
Themen:	15D instrument Acute respiratory distress syndrome COVID-19 Coronavirus Health-related quality of life

Anmerkungen:	© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021

doi:	10.1007/s11136-021-02865-7

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC2127938623

Internformat


LEADER	01000naa a22002652 4500
001	OLC2127938623
003	DE-627
005	20230505135028.0
007	cr uuu---uuuuu
008	230505s2021 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s11136-021-02865-7 \|2 doi
035			\|a (DE-627)OLC2127938623
035			\|a (DE-He213)s11136-021-02865-7-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 100 \|q VZ
084			\|a 5,1 \|2 ssgn
084			\|a PHILOS \|q DE-12 \|2 fid
084			\|a 44.52$jTherapie$XMedizin \|2 bkl
100	1		\|a Gamberini, Lorenzo \|e verfasserin \|4 aut
245	1	0	\|a Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up
264		1	\|c 2021
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021
520			\|a Purpose The onset of the coronavirus disease 19 (COVID-19) pandemic in Italy induced a dramatic increase in the need for intensive care unit (ICU) beds for a large proportion of patients affected by COVID-19-related acute respiratory distress syndrome (ARDS). The aim of the present study was to describe the health-related quality of life (HRQoL) at 90 days after ICU discharge in a cohort of COVID-19 patients undergoing invasive mechanical ventilation and to compare it with an age and sex-matched sample from the general Italian and Finnish populations. Moreover, the possible associations between clinical, demographic, social factors, and HRQoL were investigated. Methods COVID-19 ARDS survivors from 16 participating ICUs were followed up until 90 days after ICU discharge and the HRQoL was evaluated with the 15D instrument. A parallel cohort of age and sex-matched Italian population from the same geographic areas was interviewed and a third group of matched Finnish population was extracted from the Finnish 2011 National Health survey. A linear regression analysis was performed to evaluate potential associations between the evaluated factors and HRQoL. Results 205 patients answered to the questionnaire. HRQoL of the COVID-19 ARDS patients was significantly lower than the matched populations in both physical and mental dimensions. Age, sex, number of comorbidities, ARDS class, duration of invasive mechanical ventilation, and occupational status were found to be significant determinants of the 90 days HRQoL. Clinical severity at ICU admission was poorly correlated to HRQoL. Conclusion COVID-19-related ARDS survivors at 90 days after ICU discharge present a significant reduction both on physical and psychological dimensions of HRQoL measured with the 15D instrument. Trial Registration: NCT04411459.
650		4	\|a COVID-19
650		4	\|a Coronavirus
650		4	\|a Acute respiratory distress syndrome
650		4	\|a 15D instrument
650		4	\|a Health-related quality of life
700	1		\|a Mazzoli, Carlo Alberto \|4 aut
700	1		\|a Sintonen, Harri \|4 aut
700	1		\|a Colombo, Davide \|4 aut
700	1		\|a Scaramuzzo, Gaetano \|4 aut
700	1		\|a Allegri, Davide \|4 aut
700	1		\|a Tonetti, Tommaso \|4 aut
700	1		\|a Zani, Gianluca \|4 aut
700	1		\|a Capozzi, Chiara \|4 aut
700	1		\|a Giampalma, Emanuela \|4 aut
700	1		\|a Agnoletti, Vanni \|4 aut
700	1		\|a Becherucci, Filippo \|4 aut
700	1		\|a Bertellini, Elisabetta \|4 aut
700	1		\|a Castelli, Andrea \|4 aut
700	1		\|a Cappellini, Iacopo \|4 aut
700	1		\|a Cavalli, Irene \|4 aut
700	1		\|a Crimaldi, Federico \|4 aut
700	1		\|a Damiani, Federica \|4 aut
700	1		\|a Fusari, Maurizio \|4 aut
700	1		\|a Gordini, Giovanni \|4 aut
700	1		\|a Laici, Cristiana \|4 aut
700	1		\|a Lanza, Maria Concetta \|4 aut
700	1		\|a Leo, Mirco \|4 aut
700	1		\|a Marudi, Andrea \|4 aut
700	1		\|a Nardi, Giuseppe \|4 aut
700	1		\|a Ottaviani, Irene \|4 aut
700	1		\|a Papa, Raffaella \|4 aut
700	1		\|a Potalivo, Antonella \|4 aut
700	1		\|a Ranieri, Vito Marco \|4 aut
700	1		\|a Russo, Emanuele \|4 aut
700	1		\|a Taddei, Stefania \|4 aut
700	1		\|a Volta, Carlo Alberto \|4 aut
700	1		\|a Spadaro, Savino \|0 (orcid)0000-0001-5027-5318 \|4 aut
773	0	8	\|i Enthalten in \|t Quality of life research \|d Springer International Publishing, 1992 \|g 30(2021), 10 vom: 12. Mai, Seite 2805-2817 \|h Online-Ressource \|w (DE-627)320474399 \|w (DE-600)2008960-0 \|w (DE-576)121191001 \|x 1573-2649 \|7 nnns
773	1	8	\|g volume:30 \|g year:2021 \|g number:10 \|g day:12 \|g month:05 \|g pages:2805-2817
856	4	0	\|u https://dx.doi.org/10.1007/s11136-021-02865-7 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a FID-PHILOS
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_120
912			\|a GBV_ILN_138
912			\|a GBV_ILN_150
912			\|a GBV_ILN_151
912			\|a GBV_ILN_152
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_171
912			\|a GBV_ILN_187
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_224
912			\|a GBV_ILN_230
912			\|a GBV_ILN_250
912			\|a GBV_ILN_281
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_374
912			\|a GBV_ILN_602
912			\|a GBV_ILN_636
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2018
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2037
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2039
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2056
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2065
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2088
912			\|a GBV_ILN_2093
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2107
912			\|a GBV_ILN_2108
912			\|a GBV_ILN_2110
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2136
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2144
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2188
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2232
912			\|a GBV_ILN_2336
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_2470
912			\|a GBV_ILN_2474
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_2522
912			\|a GBV_ILN_2548
912			\|a GBV_ILN_2938
912			\|a GBV_ILN_2949
912			\|a GBV_ILN_2950
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4046
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4246
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4328
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4336
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4346
912			\|a GBV_ILN_4392
912			\|a GBV_ILN_4393
912			\|a GBV_ILN_4700
936	b	k	\|a 44.52$jTherapie$XMedizin \|q VZ \|0 10641593X \|0 (DE-625)10641593X
951			\|a AR
952			\|d 30 \|j 2021 \|e 10 \|b 12 \|c 05 \|h 2805-2817

Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände